Michael Shankman

Insider Reports History

Entity
Individual
Location
406 Natalie Lane, Danville, CA
Signature
/Michael Shankman/
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Insider Reports Filed by Michael Shankman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LEXX Lexaria Bioscience Corp. Oct 1, 2024 0 $0 3 Oct 2, 2024 Chief Financial Officer